The Molecular Diagnostics market report provides the detailed analysis of market size and growth, and segmentation of the industry. The analysis includes the market by value, by segments, by application, by manufacturers and by region. The market size and forecast in terms of US$ Mn for each segment has been provided for the period from 2019 to 2026. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2019 to 2026, considering 2017 as the base year. Moreover, the report assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry.
The report offers in-depth insights, revenue details, and other vital information regarding the global Molecular Diagnostics market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2026. The report also offers insightful and detailed information regarding the various key players operating in the global Molecular Diagnostics market, and their financials, apart from strategies, acquisitions & mergers, and market footprint. The global Molecular Diagnostics market is segmented on the basis of product type, end user, and region.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
ABBOTT LABORATORIES
AGILENT TECHNOLOGIES
BECTON, DICKINSON AND COMPANY
BIOMERIEUX
DANAHER
DIASORIN
GRIFOLS
HOLOGIC
ILLUMINA
QIAGEN
ROCHE DIAGNOSTICS
SIEMENS
THERMO FISHER SCIENTIFIC
Segment by Regions
North America
Europe
China
Japan
Segment by Type
PCR
DNA Sequencing
NGS
Segment by Application
Infectious Disease (Hepatitis, HIV)
Oncology
Genetic Testing
Reasons for Buying this Report
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Molecular Diagnostics Market, By Product
7.1. Molecular Diagnostics Market, by Product Type, 2021-2030
7.1.1. Instruments
7.1.1.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Molecular Diagnostics Market, By Test Location
8.1. Molecular Diagnostics Market, By Test Location, 2021-2030
8.1.1. Point-of-Care
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Self-test or Over the Counter
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Central Laboratories
8.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Molecular Diagnostics Market, By Technology
9.1. Molecular Diagnostics Market, By Technology, 2021-2030
9.1.1. Polymerase Chain Reaction (PCR)
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. In Situ Hybridization (ISH)
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Isothermal Nucleic Acid Amplification Technology (INAAT)
9.1.3.1. Market Revenue and Forecast (2016-2030)
9.1.4. Chips and Microarrays
9.1.4.1. Market Revenue and Forecast (2016-2030)
9.1.5. Mass Spectrometry
9.1.5.1. Market Revenue and Forecast (2016-2030)
9.1.6. Sequencing
9.1.6.1. Market Revenue and Forecast (2016-2030)
9.1.7. Transcription Mediated Amplification (TMA)
9.1.7.1. Market Revenue and Forecast (2016-2030)
9.1.8. Others
9.1.8.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Molecular Diagnostics Market, By Application
10.1. Molecular Diagnostics Market, By Application, 2021-2030
10.1.1. Oncology
10.1.1.1. Market Revenue and Forecast (2016-2030)
10.1.2. Pharmacogenomics
10.1.2.1. Market Revenue and Forecast (2016-2030)
10.1.3. Infectious Diseases
10.1.3.1. Market Revenue and Forecast (2016-2030)
10.1.4. Genetic Testing
10.1.4.1. Market Revenue and Forecast (2016-2030)
10.1.5. Neurological Disease
10.1.5.1. Market Revenue and Forecast (2016-2030)
10.1.6. Cardiovascular Disease
10.1.6.1. Market Revenue and Forecast (2016-2030)
10.1.7. Microbiology
10.1.7.1. Market Revenue and Forecast (2016-2030)
10.1.8. Others
10.1.8.1. Market Revenue and Forecast (2016-2030)
Chapter 11. Global Molecular Diagnostics Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2016-2030)
11.1.2. Market Revenue and Forecast, By Test Location (2016-2030)
11.1.3. Market Revenue and Forecast, By Technology (2016-2030)
11.1.4. Market Revenue and Forecast, By Application (2016-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.1.5.2. Market Revenue and Forecast, By Test Location (2016-2030)
11.1.5.3. Market Revenue and Forecast, By Technology (2016-2030)
11.1.5.4. Market Revenue and Forecast, By Application (2016-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.1.6.2. Market Revenue and Forecast, By Test Location (2016-2030)
11.1.6.3. Market Revenue and Forecast, By Technology (2016-2030)
11.1.6.4. Market Revenue and Forecast, By Application (2016-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.2. Market Revenue and Forecast, By Test Location (2016-2030)
11.2.3. Market Revenue and Forecast, By Technology (2016-2030)
11.2.4. Market Revenue and Forecast, By Application (2016-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.5.2. Market Revenue and Forecast, By Test Location (2016-2030)
11.2.5.3. Market Revenue and Forecast, By Technology (2016-2030)
11.2.5.4. Market Revenue and Forecast, By Application (2016-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.6.2. Market Revenue and Forecast, By Test Location (2016-2030)
11.2.6.3. Market Revenue and Forecast, By Technology (2016-2030)
11.2.6.4. Market Revenue and Forecast, By Application (2016-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.7.2. Market Revenue and Forecast, By Test Location (2016-2030)
11.2.7.3. Market Revenue and Forecast, By Technology (2016-2030)
11.2.7.4. Market Revenue and Forecast, By Application (2016-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.8.2. Market Revenue and Forecast, By Test Location (2016-2030)
11.2.8.3. Market Revenue and Forecast, By Technology (2016-2030)
11.2.8.4. Market Revenue and Forecast, By Application (2016-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.2. Market Revenue and Forecast, By Test Location (2016-2030)
11.3.3. Market Revenue and Forecast, By Technology (2016-2030)
11.3.4. Market Revenue and Forecast, By Application (2016-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.5.2. Market Revenue and Forecast, By Test Location (2016-2030)
11.3.5.3. Market Revenue and Forecast, By Technology (2016-2030)
11.3.5.4. Market Revenue and Forecast, By Application (2016-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.6.2. Market Revenue and Forecast, By Test Location (2016-2030)
11.3.6.3. Market Revenue and Forecast, By Technology (2016-2030)
11.3.6.4. Market Revenue and Forecast, By Application (2016-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.7.2. Market Revenue and Forecast, By Test Location (2016-2030)
11.3.7.3. Market Revenue and Forecast, By Technology (2016-2030)
11.3.7.4. Market Revenue and Forecast, By Application (2016-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.8.2. Market Revenue and Forecast, By Test Location (2016-2030)
11.3.8.3. Market Revenue and Forecast, By Technology (2016-2030)
11.3.8.4. Market Revenue and Forecast, By Application (2016-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.2. Market Revenue and Forecast, By Test Location (2016-2030)
11.4.3. Market Revenue and Forecast, By Technology (2016-2030)
11.4.4. Market Revenue and Forecast, By Application (2016-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.5.2. Market Revenue and Forecast, By Test Location (2016-2030)
11.4.5.3. Market Revenue and Forecast, By Technology (2016-2030)
11.4.5.4. Market Revenue and Forecast, By Application (2016-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.6.2. Market Revenue and Forecast, By Test Location (2016-2030)
11.4.6.3. Market Revenue and Forecast, By Technology (2016-2030)
11.4.6.4. Market Revenue and Forecast, By Application (2016-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.7.2. Market Revenue and Forecast, By Test Location (2016-2030)
11.4.7.3. Market Revenue and Forecast, By Technology (2016-2030)
11.4.7.4. Market Revenue and Forecast, By Application (2016-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.8.2. Market Revenue and Forecast, By Test Location (2016-2030)
11.4.8.3. Market Revenue and Forecast, By Technology (2016-2030)
11.4.8.4. Market Revenue and Forecast, By Application (2016-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.5.2. Market Revenue and Forecast, By Test Location (2016-2030)
11.5.3. Market Revenue and Forecast, By Technology (2016-2030)
11.5.4. Market Revenue and Forecast, By Application (2016-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.5.5.2. Market Revenue and Forecast, By Test Location (2016-2030)
11.5.5.3. Market Revenue and Forecast, By Technology (2016-2030)
11.5.5.4. Market Revenue and Forecast, By Application (2016-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.5.6.2. Market Revenue and Forecast, By Test Location (2016-2030)
11.5.6.3. Market Revenue and Forecast, By Technology (2016-2030)
11.5.6.4. Market Revenue and Forecast, By Application (2016-2030)
Chapter 12. Company Profiles
12.1. BD
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. bioMérieux SA
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Bio-Rad Laboratories, Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Abbott
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Agilent Technologies, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Danaher
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Hologic Inc. (Gen-Probe)
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Illumina, Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Johnson & Johnson Services, Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Grifols, S.A.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. QIAGEN
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
12.12. F. Hoffmann-La Roche, Ltd.
12.12.1. Company Overview
12.12.2. Product Offerings
12.12.3. Financial Performance
12.12.4. Recent Initiatives
12.13. Siemens Healthineers AG
12.13.1. Company Overview
12.13.2. Product Offerings
12.13.3. Financial Performance
12.14. Sysmex Corporation
12.14.1. Company Overview
12.14.2. Product Offerings
12.14.3. Financial Performance
12.14.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers